Fibroblast growth factor-23 and renin–angiotensin system levels in vitamin-D-dependent rickets type I
- 3 March 2016
- journal article
- case report
- Published by Springer Nature in Pediatric Nephrology
- Vol. 31 (7) , 1189-1193
Abstract
As 1,25(OH)2D3 vitamin D3 induces fibroblast growth factor-23 (FGF-23) production and suppresses the renin–angiotensin–aldosterone system (RAAS), its absence in vitamin-D-dependent rickets type I (VDDR-I) may have adverse health consequences. An infant presented at age 8 months with hypocalcemia and rickets and very low 1,25(OH)2D3 levels. Genetic analysis confirmed VDRR-I, and calcitriol therapy was initiated. During periods of nonadherence to therapy, chemical measurements revealed detectable FGF-23 levels, with undetectable 1,25(OH)2D3, hypophosphatemia, low tubular reabsorption of phosphate, hypocalcemia, and very elevated parathyroid hormone (PTH) levels. These changes, in addition to elevated RAAS levels, normalized during calcitriol therapy despite elevated FGF-23 levels. At age 12 years, all rachitic manifestations were absent, and bone mineral density (BMD) and the echocardiogram were normal. Whereas 1,25(OH)2D3 is not indispensable for FGF-23 production, PTH in the absence of vitamin D may maintain FGF-23 secretion despite hypocalcemia. Normalization of urinary phosphate losses despite elevated FGF-23 during calcitriol-mediated suppression of secondary hyperparathyroidism points to a cardinal role of PTH as a cause of the phosphaturia in VDRR-I. Normalization of RAAS by calcitriol may conceivably prevent adverse cardiovascular outcomes.Keywords
This publication has 34 references indexed in Scilit:
- Update on fibroblast growth factor 23 in chronic kidney diseaseKidney International, 2012
- Genetic disorders of phosphate regulationPediatric Nephrology, 2012
- Regulation and Function of the FGF23/Klotho Endocrine PathwaysPhysiological Reviews, 2012
- FGF23 induces left ventricular hypertrophyJournal of Clinical Investigation, 2011
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney diseaseKidney International, 2011
- PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loopAmerican Journal of Physiology-Renal Physiology, 2010
- Genetic Disorders and Defects in Vitamin D ActionEndocrinology and Metabolism Clinics of North America, 2010
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney DiseaseCirculation, 2009
- Bone mineral content and mineral metabolism during cyclosporine treatment of nephrotic syndromeThe Journal of Pediatrics, 2006
- 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin systemJournal of Clinical Investigation, 2002